The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Dry powder inhalers for pulmonary drug delivery
Abstract
The pulmonary route is an interesting route for drug administration, both for effective local therapy (asthma, chronic obstructive pulmonary disease or cystic fibrosis) and for the systemic administration of drugs (e.g., peptides and proteins). Well-designed dry powder inhalers are highly efficient systems for pulmonary drug delivery. However, they are also complicated systems, the the performance of which relies on many aspects, including the design of the inhaler (e.g., resistance to air flow and the used de-agglomeration principle to generate the inhalation aerosol), the powder formulation and the air flow generated by the patient. The technical background of these aspects, and how they may be tuned in order to obtain desired performance profiles, is reviewed. In light of the technical background, new developments and possibilities for further improvements are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prigogine, I., Stengers, I., & Pagels, H. R. (1984) · Cited by 2,468
Aerosol Technology : Properties, Behavior, and Measurement of Airborne Particles
Hinds, W. C. (1982) · Cited by 1,470
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Management of Pulmonary Disease in Patients with Cystic Fibrosis
Ramsey, B. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350307 · Cited by 502
The Ciba Collection of Medical Illustrations
(1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960040113036 · Cited by 471
Leach, C., Davidson, P., & Boudreau, R. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061346 · Cited by 430
Brocklebank, D., Ram, F., Wright, J., Barry, P., Cates, C., Davies, L., Douglas, G., Muers, M., Smith, D., & White, J. (2001) · Health Technology Assessment · doi:10.3310/hta5260 · Cited by 401
Pandey, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg477 · Cited by 388
Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying
Maa, Y.-F., Nguyen, P.-A., Sweeney, T., Shire, S. J., & Hsu, C. C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018828425184 · Cited by 356
Cited by
The History of Therapeutic Aerosols: A Chronological Review
Stein, S. W., & Thiel, C. G. (2017) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2016.1297 · Cited by 309
Pulmonary drug delivery systems for tuberculosis treatment
Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185
Metadata
- Authors
- Frijlink, H. W., & De Boer, A. H.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2004-11
- Volume
- 1
- Issue
- 1
- Pages
- 67-86
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2112679976
- Cited by
- 259
- References
- 54
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dry powder inhalers for pulmonary drug delivery. https://app.cochat.ai/papers/10.1517/17425247.1.1.67
- The paper
- Frijlink, H. W., & De Boer, A. H. (2004). Dry powder inhalers for pulmonary drug delivery. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.1.1.67
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.